SELLAS LIFE SCIENCES GROUP I - COM (SLS)

CUSIP: 81642T100

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
4,147,390
Share change
+1,561,401
Total reported value
$5,101,026
Price per share
$1.23
Number of holders
15
Value change
+$1,921,914
Number of buys
13
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 81642T100?
CUSIP 81642T100 identifies SLS - SELLAS LIFE SCIENCES GROUP I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SELLAS LIFE SCIENCES GROUP I - COM (SLS) as of Q4 2018

As of 31 Dec 2018, SELLAS LIFE SCIENCES GROUP I - COM (SLS) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,147,390 shares. The largest 10 holders included 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, OXFORD ASSET MANAGEMENT LLP, MORGAN STANLEY, Bank of New York Mellon Corp, NORTHERN TRUST CORP, and CITADEL ADVISORS LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.